Items where Author is "Marsh, Ryan"

Group by: Item Type | No Grouping
Number of items: 3.
Marsh, Ryan
ORCID: https://orcid.org/0000-0002-3790-1721, Dos Santos, Claudio
ORCID: https://orcid.org/0000-0003-0144-4327, Yule, Alexander
ORCID: https://orcid.org/0000-0002-2666-2673, Dellschaft, Neele S
ORCID: https://orcid.org/0000-0001-5483-1684, Hoad, Caroline L
ORCID: https://orcid.org/0000-0001-5483-1027, Ng, Christabella
ORCID: https://orcid.org/0000-0001-7243-3014, Major, Giles
ORCID: https://orcid.org/0000-0001-7944-3709, Smyth, Alan R
ORCID: https://orcid.org/0000-0001-5494-5438, Rivett, Damian
ORCID: https://orcid.org/0000-0002-1852-6137 and van der Gast, Christopher
ORCID: https://orcid.org/0000-0003-1101-4048
(2024)
Impact of extended Elexacaftor/Tezacaftor/Ivacaftor therapy on the gut microbiome in cystic fibrosis.
Journal of Cystic Fibrosis, 23 (5).
pp. 967-976.
ISSN 1569-1993
Marsh, Ryan (2024) The organisation and function of the gut microbiota in cystic fibrosis. Doctoral thesis (PhD), Manchester Metropolitan University.
Marsh, Ryan, Dos Santos, Claudio, Hanson, Liam, Ng, Christabella, Major, Giles, Smyth, Alan R, Rivett, Damian
ORCID: https://orcid.org/0000-0002-1852-6137 and van der Gast, Christopher
ORCID: https://orcid.org/0000-0003-1101-4048
(2023)
Tezacaftor/Ivacaftor therapy has negligible effects on the cystic fibrosis gut microbiome.
Microbiology Spectrum, 11 (5).
ISSN 2165-0497